COVAX: 400,000 doses of Comirnaty vaccine delivered to Ukraine
26/09/2022
A total of 400,000 doses of the Comirnaty mRNA vaccine against COVID-19, developed by Pfizer/BioNTech, were delivered to Ukraine this month under the framework of the EU-supported COVAX Facility.
The vaccines will be distributed throughout 23 regions in the country by the Ministry of Health of Ukraine.
“With the approach of the autumn/winter period, it is especially important to protect yourself from COVID-19, because as the experience of past years shows, the incidence increases sharply at this time,” said Ihor Kuzin, Deputy Minister of Health and Chief State Sanitary Doctor of Ukraine.
Ukraine joined COVAX with the support of Team Europe, the WHO, UNICEF and other international partners. The vaccines are being delivered by the UNICEF supply department.
Find out more
News
-
Western Ukrainian city Ivano-Frankivsk puts new EU-funded trolleybuses into service
-
Erasmus+ support to Ukraine: four years of solidarity and action
-
Blue Haven for Ukraine: the Mission launches Phase II of the Project
-
EU adopts €1.5 billion work programme to boost European and Ukrainian defence industry
-
With EU support, the European Policy Institute in Kyiv is launched
-
The EU bolsters the resilience of JSC “Ukrainian railways”